The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to the AMERICAN COLLEGE OF MEDICAL TOXICOLOGY, INC. Justification of the capability required is provided on the sole source justification document. This contract action are for services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). This notice of intent is NOT a request for competitive quotations. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/responses should be emailed to the contract specialist at
[email protected]. The Centers for Disease Control and Prevention (CDC) National Center for Injury Prevention and Control (NCIPC) is engaging in efforts to better understand drug overdose trends in the United States by using timely and comprehensive data from emergency departments, death certificates, and medical examiner/coroner reports including toxicological results. In order to complement surveillance data currently being collected by CDC’s Overdose Data to Action (OD2A) program, NCIPC is interested in access to datasources that document drug adverse events and toxicity that may result from overdose and treatment, particularly for nonfatal events. One such datasource is the Toxicology Investigators Consortium or ToxIC registry collected by the American College of Medical Toxicology (ACMT). The ToxIC registry is a nationwide repository of clinical toxicology data. The objective is to acquire one (1) Single Seat User License to access the ToxIC registry to view emerging drug toxicity data in overdose cases as recorded in this registry.